Device type · NDS
Media, Culture, Ex Vivo, Tissue And Cell
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NDS
Gastroenterology & Urology
Device class
Class II
FDA decisions since 2015
4
510(k), De Novo and PMA
Adverse event reports
0
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Media, Culture, Ex Vivo, Tissue And Cell
- Product code
- NDS
- Device class
- Class II
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.5885
- Specialty
- GI, Urology & Nephrology
- FDA record
- Classification database entry for NDS
Latest FDA decisions
- MSC SFM510(k)
Yocon Biology Technology Company
K232543 · Decided Sep 6, 2024 · 381 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
Duogenic Stemcells Corporation
K240247 · Decided Jul 12, 2024 · 164 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
K231804 · Decided Nov 9, 2023 · 142 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
- CT-STOR510(k)
K201789 · Decided Sep 20, 2021 · 447 days after receipt
Device type: Media, Culture, Ex Vivo, Tissue And Cell (NDS) · GI, Urology & Nephrology
Reports received
0
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
No reports to chart for this view.
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
No manufacturers to rank.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
No device problems coded.
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
No patient problems coded.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- StemPro MSC SFM CTS"Terminated
Z-0274-2020 · Started Jun 11, 2019
Reason given: Component was not tested by the supplier for adventitious agents
Cause as FDA categorized it: Vendor change control
Z-2542-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
- GIBCO CTS AIM V Serum-Free Media (SFM), Model Number 0870112BK. Tissue and cell culture medium.Terminated
Z-2543-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2544-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2545-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2546-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
Z-2547-2018 · Started May 10, 2018 · Posted by FDA Jul 25, 2018
Reason given: It has been determined that the fill port tube seal integrity was compromised during the manufacture of the product lot. This may cause media to leak out of the primary sterile packaging into outer non-sterile dust cover packaging, and subsequently mold may grow in the pooled, leaked media.
Cause as FDA categorized it: Unknown/Undetermined by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.